In addition, most previous studies indicate STING depletion favors cell proliferation‐ either through reducing T cell infiltrates to promote immune evasion,[20] or via regulating tumor cell cycle depending on the NF‐kB/p53 signaling,[30] thus supporting STING as a potential tumor suppressor in cancer. The gene discussed is STING1; the disease is neoplasm.